Skip to main content

Advertisement

Log in

Fungal Endocarditis Observed Over an 8-Year Period and a Review of the Literature

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Background

Fungal endocarditis (FE) is a “modern” disease that is considered an emerging cause of infective endocarditis (IE). The most frequently identified fungal pathogens are Candida spp., which are responsible for up to two-thirds of all cases; the remaining cases are due to Aspergillus spp., Histoplasma capsulatum or, more rarely, other yeasts and moulds.

Objectives

To describe the prevalence, clinical characteristics and outcome of FE diagnosed in a single tertiary centre and review the literature concerning FE.

Design and setting

An 8-year retrospective review of the case records of patients attending a single Italian University Centre and diagnosed as having definite or probable IE as defined by the modified Duke criteria.

Results

Six patients were identified from 229 episodes of IE: five cases involved a prosthetic valve, and one a native valve of an intravenous drug user. Five cases were caused by Candida spp. (two by C. albicans, one each by C. lusitaniae, C. dubliniensis and C. glabrata) and one by Aspergillus flavus. Three patients were treated by means of surgery plus antifungal therapy; two received antifungal therapy alone. Three patients survived, but only the patient with Aspergillus endocarditis was followed up for a long time.

Conclusions

FE is difficult to diagnose but generally associated with healthcare infections. The optimal treatment is poorly characterised, and international collaborative studies are urgently needed to evaluate newer antifungal agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ellis M. Fungal endocarditis. J Infect. 1997;35:99–103.

    Article  CAS  PubMed  Google Scholar 

  2. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis. 2001;32:50–62.

    Article  CAS  PubMed  Google Scholar 

  3. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995–2000. Chest. 2002;122:302–10.

    Article  PubMed  Google Scholar 

  4. Ferraris L, Milazzo L, Ricaboni D, et al. Profile of infective endocarditis observed from 2003–2010 in a single center in Italy. BMC Infect Dis. 2013;13:545.

    Article  PubMed  Google Scholar 

  5. Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354–61.

    Article  CAS  PubMed  Google Scholar 

  6. Cicalini S, Puro V, Angeletti C, Chinello P, Macrì G, Petrosillo N. Profile of infective endocarditis in a referral hospital over the last 24 years. J Infect. 2006;52:140–6.

    Article  PubMed  Google Scholar 

  7. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.

    Article  CAS  PubMed  Google Scholar 

  8. Lefort A, Chartier L, Sendid B, et al. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect. 2012;18:e99–109.

    Article  CAS  PubMed  Google Scholar 

  9. Wilson WR, Jaumin PM, Danielson GK, Giuliani ER, Washington JA III, Geraci JE. Prosthetic valve endocarditis. Ann Intern Med. 1975;82:751–6.

    Article  CAS  PubMed  Google Scholar 

  10. Bhatti S, Vilenski L, Tight R, Smego RA Jr. Histoplasma endocarditis: clinical and mycologic features and outcomes. J Infect. 2005;51:2–9.

    Article  PubMed  Google Scholar 

  11. Steinbach WJ, Perfect JR, Cabell CH, et al. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. 2005;51:230–47.

    Article  PubMed  Google Scholar 

  12. Smego RA Jr, Ahmad H. The role of fluconazole in the treatment of Candida endocarditis. A meta-analysis. Medicine. 2011;90:237–49.

    Article  CAS  PubMed  Google Scholar 

  13. Garzoni C, Nobre VA, Garbino J. Candida parapsilosis endocarditis: a comparative review of the literature. Eur J Clin Microbiol Infect Dis. 2007;26:915–26.

    Article  CAS  PubMed  Google Scholar 

  14. Kalokhe AS, Rouphael N, El Chami MF, Workowski KA, Ganesh G, Jacob JT. Aspergillus endocarditis: a review of the literature. Int J Infect Dis. 2010;14:e1040–7.

    Article  PubMed  Google Scholar 

  15. McCormack J, Pollard J. Aspergillus endocarditis 2003–2009. Med Mycol. 2011;49(Suppl 1):s30–4.

    Article  PubMed  Google Scholar 

  16. Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect. 2006;12:1060–76.

    Article  CAS  PubMed  Google Scholar 

  17. Melgar GR, Nasser RM, Gordon SM, Lytle BW, Keys TF, Longworth DL. Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital. Medicine. 1997;76:94–103.

    Article  CAS  PubMed  Google Scholar 

  18. Boland JM, Chung HH, Robberts FJL, et al. Fungal prosthetic valve endocarditis: Mayo clinic experience with a clinicopathological analysis. Mycoses. 2010;54:354–60.

    Article  PubMed  Google Scholar 

  19. Benjamin DK, Mirò JM, Hoen B, et al. Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis merged database (ICE-MD). Scand J Infect Dis. 2004;36:453–5.

    Article  PubMed  Google Scholar 

  20. Baddley JW, Benjamin DK, Patel M, et al. Candida infective endocarditis. Eur J Clin Microbiol Infect Dis. 2008;27:519–29.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Falcone M, Barzaghi N, Carosi GP, et al. Candida infective endocarditis. Report of 15 cases from a prospective multicenter study. Medicine. 2009;88:160–8.

    Article  PubMed  Google Scholar 

  22. Cobo M, Ramos A, Toquero J, et al. Aspergillus infection of implantable cardioverter–defibrillators and pacemakers: case report and literature review. Eur J Clin Microbiol Infect Dis. 2007;26:357–61.

    Article  CAS  PubMed  Google Scholar 

  23. Halawa A, Henry PD, Sarubbi FA. Candida endocarditis associated with cardiac rhythm management devices: review with current treatment guidelines. Mycoses. 2010;54:e168–74.

    Article  PubMed  Google Scholar 

  24. Riviere S, Lortholary O, Michon J, et al. Aspergillus endocarditis in the era of new antifungals: major role for antigen detection. J Infect. 2013;67:85–8.

    Article  PubMed  Google Scholar 

  25. LaBarbera M, Jacobson LB. Invasive aspergillosis in an immunocompetent patient with fever and cardiac mass. Infect Dis Rep. 2011;3:e12.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Nose K, Nishioka T, Hayashi T. Infective endocarditis due to Aspergillus following kidney transplantation. Int J Urol. 2011;18:801–2.

    Article  PubMed  Google Scholar 

  27. Palomares JC, Bernal S, Marin M, et al. Molecular diagnosis of Aspergillus fumigatus endocarditis. Diagn Microbiol Infect Dis. 2011;70:534–7.

    Article  PubMed  Google Scholar 

  28. Lazaro M, Ramos A, Ussetti P, et al. Aspergillus endocarditis in lung transplant recipients: case report and literature review. Transpl Infect Dis. 2011;13:186–91.

    Article  CAS  PubMed  Google Scholar 

  29. Jensen J, Guinea J, Torres-Narbona M, Munoz P, Pelaez T, Bouza E. Post-surgical invasive aspergillosis: an uncommon and under-appreciated entity. J Infect. 2010;60:162–7.

    Article  PubMed  Google Scholar 

  30. Philippe B, Grenet D, Honderlick P, et al. Severe Aspergillus endocarditis in a lung transplant recipient with a five-year survival. Transpl Infect Dis. 2010;12:273–6.

    Article  CAS  PubMed  Google Scholar 

  31. Badiee P, Alborzi A, Shakiba E, Ziyaeyan M, Pourabbas B. Molecular diagnosis of Aspergillus endocarditis after cardiac surgery. J Med Microbiol. 2009;58:192–5.

    Article  CAS  PubMed  Google Scholar 

  32. Morio F, Treilhaud M, Lepelletier D, et al. Aspergillus fumigatus endocarditis of the mitral valve in a heart transplant recipient: a case report. Diagn Microbiol Infect Dis. 2008;62:453–6.

    Article  PubMed  Google Scholar 

  33. Peman J, Ortiz R, Osseyran F, et al. Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review. Rev Iberoam Micol. 2007;24:157–60.

    Article  PubMed  Google Scholar 

  34. Saitoh T, Matsushima T, Matsuo A, et al. Small-bowel perforation accompanied by Aspergillus endocarditis in a patient with angioimmunoblastic T-cell lymphoma. Ann Hematol. 2007;86:71–3.

    Article  PubMed  Google Scholar 

  35. McCracken D, Barnes R, Poynton C, White PL, Isik N, Cook D. Polymerase chain reaction aids in the diagnosis of an unusual case of Aspergillus niger endocarditis in a patient with acute myeloid leukaemia. J Infect. 2003;47:344–7.

    Article  CAS  PubMed  Google Scholar 

  36. Lopez J, Revilla A, Vilacosta I, et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J. 2007;28:760–5.

    Article  PubMed  Google Scholar 

  37. Fernandez Guerrero ML, Alvarez B, Manzarbeitia F, Renedo G. Infective endocarditis at autopsy. A review of pathologic manifestations and clinical correlates. Medicine. 2012;91:152–64.

    Article  PubMed  Google Scholar 

  38. Thuny F, Fournier P-E, Casalta J-P, et al. Investigation of blood culture-negative early prosthetic valve endocarditis reveals high prevalence of fungi. Heart. 2010;96:743–7.

    Article  PubMed  Google Scholar 

  39. Grijalva M, Horvath R, Dendis M, et al. Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients. Heart. 2003;89:263–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  40. Antinori S. Histoplasma capsulatum: more widespread than previously thought. Am J Trop Med Hyg. 2014;90:982-3.

  41. Sun X-L, Zhang J, Wang G–G, et al. Comparison of characteristics and short-term outcome from fungal infective endocarditis in prosthetic valve endocarditis versus native valve endocarditis. Am J Cardiol. 2013;112:111–6.

    Article  PubMed  Google Scholar 

  42. Carr MJ, Clarke S, O’Connell F, Sullivan DJ, Coleman DC, O’Connell B. First reported case of endocarditis caused by Candida dubliniensis. J Clin Microbiol. 2005;43:3023–6.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Tran C, Cometta A, Letovanec I, et al. Candida dubliniensis in recurrent polymicrobial tricuspid endocarditis. Echocardiography. 2007;24:756–9.

    Article  PubMed  Google Scholar 

  44. Garcia J, Soch K, Matthew E, Surani S, Horseman MA. Endocarditis caused by Candida dubliniensis. Am J Med Sci. 2013;346:237–9.

    Article  PubMed  Google Scholar 

  45. Wendt B, Hagland L, Razavi A, Rath R. Candida lusitaniae, an uncommon cause of prosthetic valve endocarditis. Clin Infect Dis. 1998;26:769–70.

    Article  CAS  PubMed  Google Scholar 

  46. Michel RG, Kinasewitz GT, Drevets DA, Levin JH, Warden WD. Prosthetic valve endocarditis caused by Candida lusitaniae, an uncommon pathogen: a case report. J Med Case Rep. 2009;3:7611.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Ells R, Kock JLF, Pohl CH. Candida albicans or Candida dubliniensis? Mycoses. 2009;54:1–16.

    Article  Google Scholar 

  48. Khan Z, Ahmad S, Joseph L, Chandy R. Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen. PLoS One. 2012;7:e32952.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Pappas PG, Kaufmann CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35.

    Article  CAS  PubMed  Google Scholar 

  50. Cornerly OA, Bassetti M, Calandra T, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(Suppl. 7):19–37.

    Article  Google Scholar 

  51. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). The task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of cardiology. Eur Heart J. 2009;19:2369–413.

    Google Scholar 

  52. Gardiner BJ, Slavin MA, Korman TM, Stuart RL. Hampered by historical paradigms – echinocandins and the treatment of Candida endocarditis. Mycoses 2014;57:316–9.

  53. Kuhn DM, George T, Chandra J, et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother. 2002;46:1773–80.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Rubinstein E, Noriega ER, Simberkoff MS, et al. Tissue penetration of amphotericin B in Candida endocarditis. Chest. 1974;66:376–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Mrs. Enza Pallone for carefully selecting for the patients’ records from the in-hospital database, Dr. Alessandro Cialfi for his valuable contribution regarding echocardiography, Prof. Carlo Antona for his cardiosurgery contribution and Dr Giuliano Rizzardini for his helpful advice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Spinello Antinori.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antinori, S., Ferraris, L., Orlando, G. et al. Fungal Endocarditis Observed Over an 8-Year Period and a Review of the Literature. Mycopathologia 178, 37–51 (2014). https://doi.org/10.1007/s11046-014-9754-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-014-9754-4

Keywords

Navigation